Back to search

Article

The agonist of JWA gene JAC1 suppresses proliferation of breast cancer through JWA/p38/SMURF1/HER2 signaling

2020-03-05

Abstract excerpt

<h4>Background: </h4> The HER2-positive breast cancer accounts for 20-30% of all breast cancers. The overexpression of HER2 is associated with malignant proliferation and invasiveness in several cancers. Some HER2 targeting drugs are widely used in clinic to block HER2 or its tyrosine kinase and improve the prognosis of patients. However, drug resistance and side effects are still a big challenge worldwide. Our pr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
978eafa5-06d8-5103-9e5f-616adf5c8b50
DOI
10.21203/rs.3.rs-16181/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The agonist of JWA gene JAC1 suppresses proliferation of breast cancer through JWA/p38/SMURF1/HER2 signalingDOI 10.21203/rs.3.rs-16181/v1
Select a neighboring publication to make it the new centre.